Human pharmacokinetics, doseresponse, and mechanism validation remain limited
I dont know the answer to this, but I think right now, without having anybody being able to monitor this, I dont know how we get past just the influencer phase of people recommending this, because I dont know how were going to get there
What is BPC-157 and how is it different from a regular anti-inflammatory
Daily 1,000 mcg Dosing in the Initial Phase In the first one to two weeks, daily injections of 1,000 mcg are given
I love the packaging and the responsiveness of the customer service
Note: Dosing should be determined by your provider based on your specific condition, injury type, and treatment goals